Retour sur lavenir.net
   VASTNED 29.500 € (+0,34 %)     WDP 22.140 € (-2,64 %)     D'IETEREN GROUP 174.800 € (+0,92 %)     GBL 78.450 € (+0,58 %)     KINEPOLIS GROUP 38.100 € (0,00 %)     KBC ANCORA 87.500 € (+1,86 %)     GIMV 44.750 € (+0,45 %)     ARGENX SE 804.400 € (+0,93 %)     LOTUS BAKERIES 10 720.000 € (+0,37 %)     MELEXIS 70.650 € (-2,35 %)     UCB 246.000 € (+1,23 %)     ONTEX GROUP 2.190 € (+0,23 %)     DECEUNINCK 2.135 € (-2,95 %)     SHURGARD 25.550 € (+0,99 %)     AGFA-GEVAERT 0.371 € (+0,27 %)     CIE BOIS SAUVAGE 301.000 € (+0,33 %)     IMMOBEL 21.600 € (-0,46 %)     AGEAS 71.650 € (-0,21 %)     COLRUYT 38.000 € (-0,21 %)     AEDIFICA 70.050 € (-0,36 %)     ECONOCOM GROUP 1.410 € (-3,42 %)     ELIA GROUP 138.500 € (-0,22 %)     EXMAR 11.500 € (0,00 %)     ASCENCIO 52.300 € (0,00 %)     CMB.TECH 13.860 € (+0,87 %)     TUBIZE-FIN 209.800 € (+1,25 %)     EVS 27.050 € (+0,56 %)     SIPEF 93.100 € (+0,54 %)     BANQUP GROUP 2.100 € (0,00 %)     BEKAERT 42.050 € (+1,08 %)     PROXIMUS 6.115 € (+0,33 %)     KBC 122.400 € (+1,32 %)     NYXOAH 1.240 € (-4,62 %)     ENERGYVISION 14.900 € (+0,40 %)     JENSEN-GROUP 84.400 € (+0,48 %)     VAN DE VELDE 29.800 € (-0,67 %)     TINC 11.300 € (+0,36 %)     BREDERODE 102.400 € (+0,20 %)     FAGRON 23.250 € (+0,22 %)     VGP 84.400 € (+1,44 %)     DEME GROUP 168.000 € (+0,12 %)     UMICORE 20.280 € (+3,42 %)     SYENSQO 71.050 € (+1,57 %)     CFE 12.100 € (+1,68 %)     SOFINA 238.000 € (+1,45 %)     RETAIL ESTATES 65.900 € (+1,23 %)     BARCO 7.950 € (-0,56 %)     AZELIS GROUP 10.620 € (+0,28 %)     IBA 16.420 € (+2,11 %)     ONWARD MEDICAL 2.405 € (0,00 %)     RECTICEL 11.900 € (-0,17 %)     TESSENDERLO 20.800 € (+0,73 %)     ACKERMANS V.HAAREN 265.800 € (-0,08 %)     FLUXYS BELGIUM D 20.000 € (0,00 %)     CARE PROPERTY INV. 12.680 € (+0,48 %)     TITAN S.A. 50.450 € (+2,50 %)     CAMPINE 207.000 € (-1,43 %)     AB INBEV 71.640 € (+1,16 %)     HOME INVEST BE. 19.880 € (+0,81 %)     SOLVAY 26.420 € (-0,30 %)  
   ADVICENNE 1.648 € (+4,30 %)     KPN KON 4.101 € (-0,92 %)     ASM INTERNATIONAL 859.400 € (-1,63 %)     BNP PARIBAS ACT.A 105.920 € (+2,08 %)     SCHNEIDER ELECTRIC 268.050 € (+1,00 %)     VALEO 13.730 € (-2,31 %)     SHELL PLC 38.775 € (-1,07 %)     ING GROEP N.V. 28.950 € (+1,49 %)     ASML HOLDING 1 563.000 € (-1,03 %)     ABIVAX 112.800 € (-1,48 %)     COVIVIO 53.100 € (+0,38 %)     LEGRAND 134.300 € (-0,48 %)     2CRSI 27.580 € (+4,08 %)     DASSAULT AVIATION 299.200 € (-1,77 %)     ALTHEORA 0.400 € (+12,99 %)     TKH GROUP 42.980 € (-0,74 %)     HEINEKEN 76.420 € (+0,92 %)     ARCADIS 41.400 € (+5,08 %)     CROSSJECT 1.504 € (-2,21 %)     RISING STONE 50.000 € (+0,50 %)     EUROPLASMA 0.001 € (0,00 %)     S.E.B. 52.700 € (-4,70 %)     AKZO NOBEL 57.860 € (+2,81 %)     AYVENS 11.620 € (+0,17 %)     SAINT GOBAIN 74.160 € (+1,81 %)     BOUYGUES 47.540 € (-0,61 %)     BAM GROEP KON 11.000 € (-2,05 %)     FDJ UNITED 22.410 € (-0,22 %)     UBISOFT ENTERTAIN 4.825 € (+2,12 %)     LVMH 461.700 € (+1,80 %)     UNIFY GROUP 1.800 € (-2,91 %)     BROADPEAK 2.380 € (-9,51 %)     AALBERTS NV 41.660 € (+0,43 %)     DSM FIRMENICH AG 81.400 € (+0,94 %)     CA TOULOUSE 31 CCI 119.840 € (-1,72 %)     L'OREAL 374.700 € (+1,59 %)     STMICROELECTRONICS 46.765 € (-2,46 %)     BENETEAU 6.110 € (+1,50 %)     SARTORIUS STED BIO 167.300 € (+2,01 %)     KERING 242.300 € (+1,47 %)     PROSUS 36.755 € (+0,82 %)     CAPITAL B 0.477 € (+1,25 %)     EURAZEO 47.680 € (+5,91 %)     WORLDLINE 9.688 € (+2,67 %)     BE SEMICONDUCTOR 227.000 € (-1,26 %)     ATOS GROUP 30.080 € (+4,74 %)     TECHNIP ENERGIES 34.360 € (+1,06 %)     SIGNIFY NV 14.570 € (-8,82 %)     HEINEKEN HOLDING 70.500 € (+0,86 %)     REXEL 37.630 € (+0,24 %)     ACCOR 46.310 € (+2,07 %)     ADYEN 801.000 € (+0,70 %)     ASR NEDERLAND 69.960 € (+0,32 %)     CEGEDIM 10.100 € (-1,94 %)     SES 7.010 € (-3,11 %)     VERALLIA 18.660 € (-0,21 %)     EDENRED 26.410 € (+0,99 %)     LAKEFRONT BIOTHER. 24.500 € (-1,13 %)     THALES 236.400 € (-0,80 %)     HAVAS 18.550 € (+1,37 %)  
CIECHARGEURSINVEST
CRI - FR0000130692 - Euronext Paris
8,690 €  17:35
-0,34 %
07/07/2026 18:00

Share Buyback Offer (OPRA) favored to implement shareholder return following the sale of Novacel

Financial communication // +33 1 47 04 13 40 // comfin@chargeurs.com
www.chargeurs.com

PRESS RELEASE
Paris, 7 July 2026

Share Buyback Offer (OPRA) favored to implement shareholder return following the sale of Novacel

An OPRA: better capital allocation for the benefit of shareholders

Following up on its press release dated May 19, 2026, the Group reiterates its previous announcement that the proceeds from the sale of Novacel would notably enable the payment of an exceptional dividend by June 30, 2027. Subject to approval by the Group's governance bodies, this dividend could have amounted to €1.50 per share, representing a total amount of €36.25 million.

After reviewing the very low liquidity of the stock and its substantial discount relative to the latest published Net Asset Value (NAV) of €24.2 per share, the Board of Directors of Compagnie Chargeurs Invest considers that a public share buyback offer (Offre Publique de Rachat d'Actions – OPRA) should be the favored and more appropriate method for redistributing a portion of the Novacel sale proceeds to shareholders, instead of an exceptional dividend. This solution would offer an optimized and targeted liquidity option for shareholders, ensuring a fair return for those wishing to benefit from partial liquidity, at an identical total cost to the company.

The OPRA would provide partial liquidity on attractive financial terms for shareholders wishing to monetize their holdings. For shareholders who choose to retain their shares and support the Group's growth, the cancellation of the shares acquired through the OPRA will result in a proportional increase in their ownership stake, as well as a mechanical increase in Earnings Per Share (EPS).

This mechanism thus combines an immediate return on investment with the consolidation of future value, fairly addressing the diverse horizons of the shareholder base.

A proposed transaction at €14 per share targeting over 10% of share capital

The total amount of this OPRA would be €36.25 million, in line with the amount initially planned for the exceptional dividend. The price per share under the OPRA would be €14, a price higher than the 2024 tender offer price (which was €12 per share), subject to the conclusions of a voluntary independent expertise report that would be requested.

The formal filing of the proposed OPRA remains subject to obtaining the following approvals:

  • Agreement from certain banking and financial partners of the Group, in accordance with financing documentation;
  • Approval by the General Meeting of Shareholders, given that the proposed OPRA could cover more than 10% of the share capital.

Subject to obtaining the aforementioned approvals, the proposed OPRA could take place by the first quarter of 2027 at the latest, a shareholder return timeline that is consistent with the schedule initially anticipated. In such a scenario, Colombus Holding 1 and 2 would tender their shares to the offer in proportion to their equity stake, to prevent the transaction from having an accretive effect to their advantage.

Michaël Fribourg, Chairman and Chief Executive Officer of Compagnie Chargeurs Invest and Chairman of Colombus Holdings, stated:

"Our Group is built on industrial and commercial fundamentals of excellence, which have been further strengthened by the sale of Novacel. The current undervaluation of our stock on the stock market is disconnected from our performance, our growth trajectory, and our Net Asset Value. Seeking the best method of shareholder return guides our efforts and inspires the review of a proposed Public Share Buyback Offer.

At an equivalent cost to the company, this solution—which would not lead to an accretion for the controlling shareholder—would offer partial liquidity to interested shareholders at price conditions significantly more favorable than current market conditions."

2026 Financial Calendar

Thursday 10 September 2026   2026 First-half results

ABOUT COMPAGNIE CHARGEURS INVEST

Compagnie Compagnie Chargeurs Invest, under the brand signature ‘Architect of Rarity’, is a hybrid company that operates both as an operator and developer of businesses positioned in the exclusive market of emotional intelligence, and as an investor actively managing a portfolio of rare and prestigious assets with strong historical roots. Supported by the long-term commitment of its controlling shareholder, the Fribourg Family Group, the company implements a value-creation strategy based on the ownership, development, and enhancement of its unique portfolio of differentiated assets. As of 31 December 2025, the net asset value of Compagnie Chargeurs Invest amounts to €585 million.

The company’s shares are listed on Euronext Paris and are PEA-PME eligible.
ISIN Code: FR0000130692, Bloomberg Code: CRI:FP, Reuters Code: CRIP.PA

Financial communication // +33 1 47 04 13 40 // comfin@chargeurs.com
www.chargeurs.com

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière